Application

15828644 · COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS

Filed 2017-12-01 · Abandoned The official file ↗ · Art unit 1627 · Examiner Irina Neagu Typical · CPC C07D 405/12 · Boehringer Ingelheim International GmbH · C/O VP, IP, LEGAL

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

2.2 mo

to disposition 10.3 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.